Skip to content

An exploratory randomized controlled study of electroacupuncture for chronic coronary syndrome based on acupoint sensitization theory

An exploratory randomized controlled study of electroacupuncture for chronic coronary syndrome based on acupoint sensitization theory

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000051
Enrollment
Unknown
Registered
2025-01-09
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic coronary syndrome

Interventions

Control group:Regular drugs only
Sensitization area group:Electroacupuncture and regular drugs treatment and the stimulation areas are the four sensitization areas on the inner side of the left arm S1 S2 S3 and S4
Normal acupoint group:Electroacupuncture and regular drugs treatment and the stimulation areas are the left arm Neiguan (PC6) Tongli (HT5) Ximen (PC4) and Shenmen (HT7)

Sponsors

Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)Patients who meet the diagnostic criteria for chronic coronary syndrome according to the Guidelines for the Diagnosis of Chronic Coronary Syndrome issued by the European Society of Cardiology (ESC) in 2019 (2) The patient can answer clearly(3) Age18 to 65 years (inclusive of 18 and 65 years); (4) Patient has experienced angina attacks for at least two weeks lasting three months or longer and the frequency and severity of each attack are essentially constant; (5) Patient has not received appropriate acupuncture treatment in the last 3 months; (6) Patients are willing to participate in the trial and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1)Patients have previous myocardial infarction severe heart failure valvular heart disease severe cardiac arrhythmia primary cardiomyopathy hematologic disorders hypertension hyperglycemia and other serious cerebrovascular diseases;(2) Patients feel localized skin peripheral nerve abnormalities; (3) Patients are pregnant breastfeeding or mentally ill; (4) Patient have other serious heart and brain diseases; (5) Patients are participating in other clinical trials; (6) Patient are bleeding allergic. Note: Patients are excluded if they meet any of these criteria.

Design outcomes

Primary

MeasureTime frame
Angina frequency;

Secondary

MeasureTime frame
Seattle Angina Questionnaire;Self-rating depression scale;Adverse events;Duration of each angina;Change of the pain threshold;Self-Rating Anxiety Scale;Visual Analogue Scale score;6-min walking distance;

Countries

China

Contacts

Public ContactQiao Haifa

Shaanxi University of Chinese Medicine

1511006@sntcm.edu.cn18220046518

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026